Applications of protein microarrays for biomarker discovery

Proteomics - Clinical Applications

Volumn 2, Issue 10-11, 2008, Pages 1444-1459

  Ramachandran, Niroshan ^a   Srivastava, Sanjeeva ^a   LaBaer, Joshua ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antibody array; Autoantibodies; Autoantigens; Biochip; Biomarkers

Indexed keywords

BIOLOGICAL MARKER; KALLEKREIN 11; MEMBRANE PROTEIN; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; AUTOIMMUNE DISEASE; BINDING AFFINITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLADDER CANCER; CANCER DIAGNOSIS; CELL LYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN VITRO TRANSCRIPTION AND TRANSLATION; OPEN READING FRAME; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVERSE CAPTURE ARRAY; REVERSE PHASE ARRAY; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 67449161036     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800032     Document Type: Review

References (89)

1. Frank, R., Hargreaves, R., Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2003, 2, 566-580.
2. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
3. Sommerer, C., Giannitsis, E., Schwenger, V., Zeier, M., Cardiac biomarkers in haemodialysis patients: The prognostic value of amino-terminal proB-type natriuretic peptide and cardiac troponin T. Nephron Clin. Pract. 2007, 107, c77-c81.
4. Sokoll, L. J., Chan, D. W., Prostate-specific antigen. Its discovery and biochemical characteristics. Urol. Clin. North Am. 1997, 24, 253-259.
5. Rustin, G. J., Bast, R. C., Jr., Kelloff, G. J., Barrett, J. C. et al., Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin. Cancer Res. 2004, 10, 3919-3926.
6. Keren, D. F., Antinuclear antibody testing. Clin. Lab. Med. 2002, 22, 447-474.
7. Baker, M., In biomarkers we trust? Nat. Biotechnol. 2005, 23, 297-304.
8. Haab, B., Dunham, M., Brown, P., Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001, 2, research/ 0004.1-13.
9. Sreekumar, A., Nyati, M. K., Varambally, S., Barrette, T. R. et al., Profiling of cancer cells using protein microarrays: Discovery of novel radiation-regulated proteins. Cancer Res. 2001, 61, 7585-7593.
10. Huang, R. P., Huang, R., Fan, Y., Lin, Y., Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal. Biochem. 2001, 294, 55-62.
11. Anderson, K. S., LaBaer, J., The sentinel within: Exploiting the immune system for cancer biomarkers. J. Proteome Res. 2005, 4, 1123-1133.
12. Miller, J. C., Zhou, H., Kwekel, J., Cavallo, R. et al., Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers. Proteomics 2003, 3, 56-63.
13. Hudelist, G., Pacher-Zavisin, M., Singer, C. F., Holper, T. et al., Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat. 2004, 86, 281-291.
14. Shafer, M. W., Mangold, L., Partin, A. W., Haab, B. B., Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 2007, 67, 255-267.
15. Sanchez-Carbayo, M., Socci, N. D., Lozano, J. J., Haab, B. B. et al., Profiling bladder cancer using targeted antibody arrays. Am. J. Pathol. 2006, 168, 93-103.
16. Orchekowski, R., Hamelinck, D., Li, L., Gliwa, E. et al., Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res. 2005, 65, 11193-11202.
17. Gao, W. M., Kuick, R., Orchekowski, R. P., Misek, D. E. et al., Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005, 5, 110.
18. Wingren, C., Ingvarsson, J., Lindstedt, M., Borrebaeck, C. A. et al., Recombinant antibody microarrays-a viable option? Nat. Biotechnol. 2003, 21, 223.
19. Söderlind, E., Strandberg, L., Jirholt, P., Kobayashi, N. et al., Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 2000, 18, 852-856.
20. Borrebaeck, C. A., Ohlin, M., Antibody evolution beyond Nature. Nat. Biotechnol., 2002, 20, 1189-1190.
21. Ingvarsson, J., Larsson, A., Sjöholm, A. G., Truedsson, L. et al., Design of recombinant antibody microarrays for serum protein profiling: Targeting of complement proteins. J. Proteome Res. 2007, 6, 3527-3536.
22. Kusnezow, W., Banzon, V., Schröder, C., Schaal, R. et al., Antibody microarray-based profiling of complex specimens: Systematic evaluation of labeling strategies. Proteomics 2007, 7, 1786-1799.
23. Wingren, C., Ingvarsson, J., Dexlin, L., Szul, D. et al., Design of recombinant antibodymicroarrays for complex proteome analysis: Choice of sample labeling-tag and solid support. Proteomics 2007, 7, 3055-3065.
24. Ellmark, P., Ingvarsson, J., Carlsson, A., Lundin, B. S. et al., Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarrays. Mol. Cell. Proteomics 2006, 5, 1638-1646.
25. Carlsson, A., Wingren, C., Ingvarsson, J., Ellmark, P. et al., Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur. J. Cancer 2008, 44, 472-480.
26. Charboneau, L., Tory, H., Chen, T., Winters, M. et al., Utility of reverse phase protein arrays: Applications to signalling pathways and human body arrays. Brief. Funct. Genomic Proteomic 2002, 1, 305-315.
27. Calvo, K. R., Liotta, L. A., Petricoin, E. F., Clinical proteomics: From biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci. Rep. 2005, 25, 107-125.
28. Paweletz, C. P., Charboneau, L., Bichsel, V. E. et al., Reverse phase protein microarrays which capture disease progression show activation of prosurvival pathways at the cancer invasion front. Oncogene 2001, 20, 1981-1999.
29. Wulfkuhle, J. D., Aquino, J. A., Calvert, V. S., Fishman, D. A. et al., Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 2003, 3, 2085-2590.
30. Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y. et al., Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics 2005, 4, 346-355.
31. Grubb, R. L., Calvert, V. S., Wulkuhle, J. D., Paweletz, C. P. et al., Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003, 3, 2142-2146.
32. Cowherd, S. M., Espina, V. A., Petricoin, E. F. III, Liotta, L. A., Proteomic analysis of human breast cancer tissue with lasercapture microdissection and reverse-phase protein microarrays. Clin. Breast Cancer 2004, 5, 385-392.
33. Akkiprik, M., Nicorici, D., Cogdell, D., Jia, Y. J. et al., Dissection of signaling pathways in fourteen breast cancer cell lines using reverse-phase protein lysate microarray. Technol. Cancer Res. Treat. 2006, 5, 543-551.
34. Speer, R., Wulfkuhle, J. D., Liotta, L. A., Petricoin, E. F. III, Reverse phase protein microarrays for tissue-based analysis. Curr. Opin. Mol. Ther. 2005, 7, 240-245.
35. Machida, K., Thompson, C.M., Dierck, K., Jablonowski, K. et al., High-throughput phosphotyrosine profiling using SH2 domains. Mol. Cell. 2007, 26, 899-915.
36. Petricoin, E. F. III, Espina, V., Araujo, R. P., Midura, B. et al., Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res. 2007, 67, 3431-3440.
37. Zhang, Q., Bhola, N. E., Lui, V. W., Siwak, D. R. et al., Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol. Cancer Ther. 2007, 6, 1414-1424.
38. Fan, Y. H., Hu, Z., Li, C., Wang, L. E. et al., In vitro expression levels of cell-cycle checkpoint proteins are associated with cellular DNA repair capacity in peripheral blood lymphocytes: A multivariate analysis. J. Proteome Res. 2007, 6, 1560-1567.
39. Yokoyama, T., Kondo, Y., Kondo, S., Roles of mTOR and STAT3 in autophagy induced by telomere 3′ overhang-specific DNA oligonucleotides. Autophagy 2007, 3, 496-498.
40. Aoki, H., Iwado, E., Eller, M. S., Kondo, Y. et al., Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J. 2007, 21, 2918-2930.
41. VanMeter, A., Signore, M., Pierobon, M., Espina, V. et al., Reverse-phase protein microarrays: Application to biomarker discovery and translational medicine. Expert. Rev. Mol. Diagn. 2007, 7, 625-633.
42. Nishizuka, S., Charboneau, L., Young, L., Major, S. et al., Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. USA 2003, 100, 14229-14234.
43. Nishizuka, S., Chen, S. T., Gwadry, F. G., Alexander, J. et al., Diagnostic markers that distinguish colon and ovarian adenocarcinomas: Identification by genomic, proteomic, and tissue array profiling. Cancer Res. 2003, 63, 5243-5250.
44. Nishizuka, S., Profiling cancer stem cells using protein array technology. Eur. J. Cancer 2006, 42, 1273-1282.
45. Chatterjee, M., Mohapatra, S., Ionan, A., Bawa, G. et al., Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res. 2006, 66, 1181-1190.
46. Wang, X., Yu, J., Sreekumar, A., Varambally, S. et al., Autoantibody signatures in prostate cancer. N. Engl. J. Med. 2005, 353, 1224-1235.
47. Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O. et al., A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 1997, 94, 1914-1918.
48. Chen, Y. T., Gure, A. O., Tsang, S., Stockert, E. et al., Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA 1998, 95, 6919-6923.
49. Chen Y. T, S. M., Obata, Y., Old, L. J. (Eds.), Identification of Human Tumor Antigens by Serological Expression Cloning. Principles and Practice of the Biologic Therapy of Cancer, Lippincott Williams & Wilkins, Philadelphia 2000, pp. 557-570.
50. Chen, Y. T., Identification of human tumor antigens by serological expression cloning: An online review on SEREX. Cancer Immun. 2004, http://www.cancerimmunity.org/SEREX/.
51. Chen, Y. T., Gure, A. O., Scanlan, M. J., Serological analysis of expression cDNA libraries (SEREX): An immunoscreening technique for identifying immunogenic tumor antigens. Methods Mol. Med. 2005, 103, 207-216.
52. Joos, T. O., Schrenk, M., Hopfl, P., Kroger, K. et al., A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000, 21, 2641-2650.
53. Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B. et al., Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 2002, 8, 295-301.
54. Bussow, K., Nordhoff, E., Lubbert, C., Lehrach, H., Walter, G., A human cDNA library for high-throughput protein expression screening. Genomics 2000, 65, 1-8.
55. Horn, S., Lueking, A., Murphy, D., Staudt, A. et al., Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Proteomics 2006, 6, 605-613.
56. Lueking, A., Horn, M., Eickhoff, H., Bussow, K. et al., Protein microarrays for gene expression and antibody screening. Anal. Biochem. 1999, 270, 103-111.
57. Lueking, A., Huber, O., Wirths, C., Schulte, K. et al., Profiling of alopecia areata autoantigens based on proteinmicroarray technology. Mol. Cell. Proteomics 2005, 4, 1382-1390.
58. Eyles, J. E., Unal, B., Hartley, M. G., Newstead, S. L. et al., Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics 2007, 7, 2172-2183.
59. Li, B., Jiang, L., Song, Q., Yang, J. et al., Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect. Immun. 2005, 73, 3734-3739.
60. Murthy, T., Rolfs, A., Hu, Y., Shi, Z. et al., A full-genomic sequence-verified protein-coding gene collection for Francisella tularensis. PLoS ONE 2007, 2, e577.
61. Janeway, C. A., Immunobiology: The immune System in Health and Disease, 6th Edn., Garland Science, NY, 2005.
62. Hu, Y., Rolfs, A., Bhullar, B., Murthy, T. V. et al., Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res. 2007, 17, 536-543.
63. Labaer, J., Qiu, Q., Anumanthan, A., Mar, W. et al., The Pseudomonas aeruginosa PA01 gene collection. Genome Res. 2004, 14, 2190-2200.
64. Zuo, D., Mohr, S. E., Hu, Y., Taycher, E. et al., PlasmID: A centralized repository for plasmid clone information and distribution. Nucleic Acids Res. 2007, 35, D680-D684.
65. Pedersen, S. K., Sloane, A. J., Prasad, S. S., Sebastian, L. T. et al., An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: Application to cystic fibrosis. Mol. Cell. Proteomics 2005, 4, 1052-1060.
66. Steller, S., Angenendt, P., Cahill, D. J., Heuberger, S. et al., Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Proteomics 2005, 5, 2048-2055.
67. Zhu, H., Hu, S., Jona, G., Zhu, X. et al., Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc. Natl. Acad. Sci. USA 2006, 103, 4011-4016.
68. Davies, D. H., Liang, X., Hernandez, J. E., Randall, A. et al., Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. USA 2005, 102, 547-552.
69. Davies, D. H., Wyatt, L. S., Newman, F. K., Earl, P. L. et al., Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J. Virol. 2008, 82, 652-663.
70. Davies, D. H., Molina, D. M., Wrammert, J., Miller, J. et al., Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 2007, 7, 1678-1686.
71. Murthy, T. V., Wu, W., Qiu, Q. Q., Shi, Z. et al., Bacterial cellfree system for high-throughput protein expression and a comparative analysis of Escherichia coli cell-free and whole cell expression systems. Protein Expr. Purif. 2004, 36, 217-225.
72. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C. et al., Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921.
73. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W. et al., The sequence of the human genome. Science 2001, 291, 1304-1351.
74. Robinson, W. H., Antigen arrays for antibody profiling. Curr. Opin. Chem. Biol. 2006, 10, 67-72.
75. Bouwman, K., Qiu, J., Zhou, H., Schotanus, M. et al., Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 2003, 3, 2200-2207.
76. Qiu, J., Madoz-Gurpide, J., Misek, D. E., Kuick, R. et al., Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res. 2004, 3, 261-267.
77. Madoz-Gurpide, J., Kuick, R., Wang, H., Misek, D. E., Hanash, S. M., Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Mol. Cell. Proteomics 2008, 7, 268-281.
78. Forrester, S., Qiu, J., Mangold, L., Partin, A. et al., Ion experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarrays. Proteomics Clin. Appl. 2007, 1, 494-505.
79. Qin, S., Qiu, W., Ehrlich, J. R., Ferdinand, A. S. et al., Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics 2006, 6, 3199-3209.
80. Ehrlich, J. R., Cauazzo, R., Qiu, W., Tassinari, O. et al., A natie antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera. Proteomics Clin. Appl. 2007, 1, 476-485.
81. Temple, G., Lamesch, P., Milstein, S., Hill, D. E. et al., From genome to proteome: Developing expression clone resources for the human genome. Hum. Mol. Genet. 2006, 15, R31-R43.
82. Rolfs, A., Hu, Y., Ebert, L. D. H. et al., A Biomedically enriched collection of 7000 human ORF clones. PLOS ONE 2008, 3, e1528.
83. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., Snyder, M., Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. USA 2007, 104, 17494-17499.
84. Smith, L., Watson, M. B., O'Kane, S. L., Drew, P. J. et al., The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol. Cancer Ther. 2006, 5, 2115-2120.
85. Schweitzer, B., Roberts, S., Grimwade, B., Shao, W. et al., Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 2002, 20, 359-365.
86. Lin, Y., Huang, R., Chen, L., Li, S. et al., Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer 2004, 109, 507-515.
87. Vazquez-Martin, A., Colomer, R., Menendez, J. A., Protein array technology to detect HER2 (erbB-2)-induced'cytokine signature' in breast cancer. Eur. J. Cancer 2007, 43, 1117-1124.
88. Sanchez-Carbayo, M., Socci, N. D., Richstone, L., Corton, M. et al., Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression. Am. J. Pathol. 2007, 171, 1650-1658.
89. Zhong, L., Coe, S. P., Stromberg, A. J., Khattar, N. H. et al., Profiling tumor-associated antibodies for early detection of nonsmall cell lung cancer. J. Thorac. Oncol. 2006, 1, 513-519.